The House Energy and Commerce Health Subcommittee today approved legislation that would prohibit Medicare and private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance. Some health insurance contracts prevent pharmacists from informing patients when the cash price for their prescription costs less than their insurance cost-sharing arrangement unless the individual asks. The subcommittee also approved a bill that would allow the Centers for Medicare & Medicaid Services to provide certain drug rebate information to the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment Advisory Commission to inform their recommendations on drug-related issues.

Related News Articles

Headline
The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption…
Headline
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the…
Headline
Health and Human Services Secretary Alex Azar today released a plan outlining two pathways the administration intends to explore to safely import certain drugs…
Headline
The House of Representatives today passed and sent to the President a Medicaid-related bill (H.R. 3253) that includes a provision extending the Certified…
Headline
Medicaid disproportionate share hospital payments to eligible hospitals covered 51% of their uncompensated care costs in 2014, the most recently available…
Headline
The Senate Finance Committee today voted 19-9 to pass the Prescription Drug Pricing Reduction Act, legislation to reduce drug costs.